Source: Drug Store News

Teva Generics: Teva intros generic Cytomel

Teva's generic Cytomel is used as a replacement therapy for certain cases of underactive thyroid (hypothyroidism); as an add-on therapy to surgery and radioiodine therapy in the management of thyroid cancer; and as a diagnostic therapy in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Allan Oberman's photo - President & CEO of Teva Generics

President & CEO

Allan Oberman

CEO Approval Rating

68/100

Read more